Japan's H1N1 Pandemic Prompts New Protective Mask By Unicharm
This article was originally published in PharmAsia News
Executive SummaryWith Japan's H1N1 flu in a pandemic stage, Unicharm plans to launch on Sept. 28 a six-layer face mask to serve as a barrier to the disease. Demand for protective masks has surged in Japan as it faces the second wave of the disease. The mask is coated with silver ions to trap the virus and is the company's response to the rapid spread of H1N1 cases in Japan. (Click here for more - a subscription may be required
You may also be interested in...
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.